IBA 50:50 by 2030 Progress Report was released by the IBA Legal Policy & Research Unit (LPRU) in collaboration with the LexisNexis Rule of Foundation
The review explores the role of gut microbiota in high-altitude adaptation, highlighting how microbial alterations impact host physiology and metabolism under hypoxic conditions and discussing potential strategies for enhancing acclimatization through microbiota modulation.
The article discusses the discovery of the A673V mutation in the amyloid precursor protein (APP) gene, which is associated with the familial form of Alzheimer's disease (AD) in a homozygous state. It provides an in-depth review of the molecular insights and therapeutic potential of the A?A2V peptide, including the development of a neuroprotective peptide A?1-6A2V(D) that inhibits amyloid-? aggregation and toxicity in preclinical models of AD and primary tauopathies
